MedTrace Logo

Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

NCT04165369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10568

Last updated 2022-07-21

No results posted yet for this study

Summary

The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials.

The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.

Conditions

  • Acute Kidney Injury (AKI)

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Alexander Zarbock, MD, PhD · University Hospital Muenster, Dept. of Anesthesiology, Intensive Care and Pain Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2022-02-28
Completion
2022-03-31

Countries

  • United States
  • Egypt
  • France
  • Germany
  • Italy
  • Libya
  • Malta
  • North Macedonia
  • Palestinian Territories
  • Russia
  • Saudi Arabia
  • Slovenia
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04165369 on ClinicalTrials.gov